Literature DB >> 21540381

Pathogenesis of Japanese encephalitis virus infection in a golden hamster model and evaluation of flavivirus cross-protective immunity.

Angela Bosco-Lauth1, Gary Mason, Richard Bowen.   

Abstract

Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus endemic to Southeast Asia and surrounding Pacific Islands, and it has most recently emerged in northern Australia. JEV is closely related to West Nile virus (WNV) and St. Louis encephalitis virus (SLEV), both endemic to the United States. In the event that JEV is introduced into the Americas, it will be important to determine whether immunity to WNV or SLEV might afford protection from infection and development of viremia in susceptible hosts. We investigated a hamster model of JEV infection and showed that a large fraction of animals infected with either a genotype I or III isolate of virus developed viremia and encephalitic lesions without clinical signs of disease. Using this model, we showed that prior infection with WNV or SLEV, vaccination using a chimeric WNV vaccine, and passive immunization with anti-JEV immune sera prevented viremia in hamsters challenged with JEV.

Entities:  

Mesh:

Year:  2011        PMID: 21540381      PMCID: PMC3083739          DOI: 10.4269/ajtmh.2011.11-0012

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  40 in total

Review 1.  The Japanese encephalitis serological group of flaviviruses: a brief introduction to the group.

Authors:  J S Mackenzie; A D T Barrett; V Deubel
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

2.  Phylogenetic analysis of Japanese encephalitis virus: envelope gene based analysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent.

Authors:  P D Uchil; V Satchidanandam
Journal:  Am J Trop Med Hyg       Date:  2001-09       Impact factor: 2.345

Review 3.  Japanese encephalitis.

Authors:  P M Ellis; P W Daniels; D J Banks
Journal:  Vet Clin North Am Equine Pract       Date:  2000-12       Impact factor: 1.792

4.  Survival of mice immunized with monoclonal antibodies against glycoprotein E of Japanese encephalitis virus before or after infection with Japanese encephalitis, West Nile, and Dengue viruses.

Authors:  A K Gupta; V J Lad; A A Koshy
Journal:  Acta Virol       Date:  2008       Impact factor: 1.162

5.  Long-term disability from acute childhood Japanese encephalitis in Shanghai, China.

Authors:  Ding Ding; Zhen Hong; Shou-Jun Zhao; John D Clemens; Bin Zhou; Bei Wang; Mao-Sheng Huang; Jun Zeng; Qi-Hao Guo; Wei Liu; Fang-Biao Tao; Zhi-Yi Xu
Journal:  Am J Trop Med Hyg       Date:  2007-09       Impact factor: 2.345

6.  Epidemiology of neuroinvasive arboviral disease in the United States, 1999-2007.

Authors:  Carolyn A Reimann; Edward B Hayes; Carolyn DiGuiseppi; Richard Hoffman; Jennifer A Lehman; Nicole P Lindsey; Grant L Campbell; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2008-12       Impact factor: 2.345

7.  Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis.

Authors:  Robert B Tesh; Amelia P A Travassos da Rosa; Hilda Guzman; Tais P Araujo; Shu-Yuan Xiao
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

8.  A curious coincidence: mosquito biodiversity and the limits of the Japanese encephalitis virus in Australasia.

Authors:  Stéphane Hemmerter; Jan Slapeta; Andrew F van den Hurk; Robert D Cooper; Peter I Whelan; Richard C Russell; Cheryl A Johansen; Nigel W Beebe
Journal:  BMC Evol Biol       Date:  2007-06-29       Impact factor: 3.260

9.  Past, present, and future of Japanese encephalitis.

Authors:  Tobias E Erlanger; Svenja Weiss; Jennifer Keiser; Jürg Utzinger; Karin Wiedenmayer
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

10.  Change in Japanese encephalitis virus distribution, Thailand.

Authors:  Narong Nitatpattana; Audrey Dubot-Pérès; Meriadeg Ar Gouilh; Marc Souris; Philippe Barbazan; Sutee Yoksan; Xavier de Lamballerie; Jean-Paul Gonzalez
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883

View more
  18 in total

Review 1.  Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.

Authors:  Mario Lobigs; Michael S Diamond
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

Review 2.  The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system.

Authors:  David C Clark; Aaron C Brault; Elizabeth Hunsperger
Journal:  Arch Virol       Date:  2012-05-17       Impact factor: 2.574

3.  A replication-defective Japanese encephalitis virus (JEV) vaccine candidate with NS1 deletion confers dual protection against JEV and West Nile virus in mice.

Authors:  Na Li; Zhe-Rui Zhang; Ya-Nan Zhang; Jing Liu; Cheng-Lin Deng; Pei-Yong Shi; Zhi-Ming Yuan; Han-Qing Ye; Bo Zhang
Journal:  NPJ Vaccines       Date:  2020-08-05       Impact factor: 7.344

4.  A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine.

Authors:  Jue Hou; Shuhui Wang; Manxue Jia; Dan Li; Ying Liu; Zhengpeng Li; Hong Zhu; Huifang Xu; Meiping Sun; Li Lu; Zhinan Zhou; Hong Peng; Qichen Zhang; Shihong Fu; Guodong Liang; Lena Yao; Xuesong Yu; Lindsay N Carpp; Yunda Huang; Julie McElrath; Steve Self; Yiming Shao
Journal:  J Immunol       Date:  2017-07-07       Impact factor: 5.422

5.  JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody.

Authors:  Maximilian Larena; Natalie A Prow; Roy A Hall; Nikolai Petrovsky; Mario Lobigs
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

6.  An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody.

Authors:  Nikolai Petrovsky; Maximilian Larena; Venkatraman Siddharthan; Natalie A Prow; Roy A Hall; Mario Lobigs; John Morrey
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

7.  North American birds as potential amplifying hosts of Japanese encephalitis virus.

Authors:  Nicole Nemeth; Angela Bosco-Lauth; Paul Oesterle; Dennis Kohler; Richard Bowen
Journal:  Am J Trop Med Hyg       Date:  2012-08-27       Impact factor: 2.345

8.  Flavivirus-induced antibody cross-reactivity.

Authors:  Karen L Mansfield; Daniel L Horton; Nicholas Johnson; Li Li; Alan D T Barrett; Derek J Smith; Sareen E Galbraith; Tom Solomon; Anthony R Fooks
Journal:  J Gen Virol       Date:  2011-09-07       Impact factor: 3.891

9.  Development of a Hamster Model for Chikungunya Virus Infection and Pathogenesis.

Authors:  Angela M Bosco-Lauth; Sushan Han; Airn Hartwig; Richard A Bowen
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

10.  Japanese encephalitis virus disrupts cell-cell junctions and affects the epithelial permeability barrier functions.

Authors:  Tanvi Agrawal; Vats Sharvani; Deepa Nair; Guruprasad R Medigeshi
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.